thiazoles has been researched along with benzylamine in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chopard, C; Chottard, JC; Cucurou, C; Daniel, R; Mansuy, D; Michaud-Soret, I; Ullrich, V | 1 |
Kaller, MR; Liu, G; Magal, E; Nguyen, TT; Norman, MH; Osslund, TD; Powers, D; Rzasa, RM; Santora, VJ; Viswanadhan, VN; Wang, HL; Xiong, X; Zhong, W | 1 |
Abe, H; Morita, H; Sakai, M; Sheikh, MC; Takagi, S | 1 |
Deng, Y; Li, Y; Liu, H; Song, Q; Tan, Z; Xiao, G; Xu, R; Yang, Z; Zhang, X; Zheng, Y | 1 |
4 other study(ies) available for thiazoles and benzylamine
Article | Year |
---|---|
Soybean lipoxygenases-1, -2a, -2b and -2c do not contain PQQ.
Topics: Benzothiazoles; Benzylamines; Binding Sites; Coenzymes; Cyclohexylamines; Electron Spin Resonance Spectroscopy; Glycine max; Hydrazones; Isoenzymes; Lipoxygenase; Phenylhydrazines; PQQ Cofactor; Quinolones; Spectrophotometry, Ultraviolet; Thiazoles | 1990 |
Structure-activity relationships of 3,4-dihydro-1H-quinazolin-2-one derivatives as potential CDK5 inhibitors.
Topics: Benzimidazoles; Benzyl Compounds; Benzylamines; Binding Sites; Crystallography, X-Ray; Cyclin-Dependent Kinase 5; Hydrogen; Inhibitory Concentration 50; Isomerism; Models, Molecular; Molecular Structure; Oxadiazoles; Protein Kinase Inhibitors; Quinazolinones; Structure-Activity Relationship; Thiadiazoles; Thiazoles | 2007 |
First synthesis of non-symmetrical "phthalimidoyl active ester" bi-dentate cross-linking reagents having an acid chloride, 2-benzothiazole, or 1-benzotriazol group.
Topics: Antigens; Benzylamines; Chlorides; Cholesterol; Cross-Linking Reagents; Esters; Phthalimides; Proteins; Substrate Specificity; Thiazoles; Triazoles | 2008 |
Multifunctional 5,6-dimethoxybenzo[d]isothiazol-3(2H)-one-N-alkylbenzylamine derivatives with acetylcholinesterase, monoamine oxidases and β-amyloid aggregation inhibitory activities as potential agents against Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Benzylamines; Blood-Brain Barrier; Cholinesterase Inhibitors; Drug Design; Humans; Kinetics; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Permeability; Protein Aggregates; Recombinant Proteins; Structure-Activity Relationship; Thiazoles | 2018 |